Holen Sie sich die Stockscreener-App
12.37
2.87%
0.345
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
AngioDynamics (ANGO) Advances Pancreatic Cancer Treatment with N - GuruFocus
AngioDynamics study shows survival benefit for pancreatic cancer - Investing.com
A pancreatic cancer study linked an electrical-pulse approach to 28 months’ median survival versus 15. - Stock Titan
AngioDynamics: Progress Evident, But Volatility And Margin Concerns Persist (NASDAQ:ANGO) - Seeking Alpha
Humana applies Medicare coverage rules to a non-heat treatment for some prostate and liver cancer patients. - Stock Titan
A Look at AngioDynamics Inc (ANGO) After 4.4% Decline -- GF Value $10.48 vs Price $10.90 - GuruFocus
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
ANGIODYNAMICS INC ($ANGO) President, CEO 2026 Pay Revealed - Quiver Quantitative
AngioDynamics CLO Received Pay Boost To $1.5M Last Year - Law360
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates - Zacks Investment Research
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability - Yahoo Finance
AngioDynamics Q1 Earnings Call Highlights - TradingView
AngioDynamics, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
With its CEO set to retire, AngioDynamics (ANGO) names a Getinge executive as successor. - Stock Titan
AngioDynamics, Inc. 2027 Q1ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-10-08 - Seeking Alpha
AngioDynamics, Inc. reports results for the quarter ended August 31Earnings Summary - TradingView
AngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech Growth - Yahoo Finance
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer - Yahoo Finance
AngioDynamics: Fiscal Q1 Earnings Snapshot - Yahoo Finance
AngioDynamics stock slips 4% despite beating estimates on Med Tech growth - Yahoo Finance
AngioDynamics Inc (ANGO) (Q1 2027) Earnings Call Highlights: MedTech Momentum Drives 6. ... - Yahoo Finance
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Why AngioDynamics Crashed Today - Yahoo Finance
ANGIODYNAMICS Q1 2027 Earnings Preview: Recent $ANGO Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
AngioDynamics, Inc. (ANGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
A Bronx hospital won a research award to test if scans can predict clot-removal success. - Stock Titan
A successor's appointment could set the CEO's retirement date at AngioDynamics (ANGO). There's another trigger. - Stock Titan
AngioDynamics Fiscal 2026 Net Loss Widens to $36.7 Million - Minichart
Sales reached $320.2 million at AngioDynamics (ANGO). Five executives received cash bonuses. - Stock Titan
AngioDynamics, Inc. (ANGO) stock price, news, quote and history - Yahoo Finance UK
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026 - Yahoo Finance Australia
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026 - Yahoo Finance
AngioDynamics, Inc. expected to post a loss of 11 cents a shareEarnings Preview - TradingView
How Angiodynamics Inc. (ANGO) Affects Rotational Strategy Timing - Stock Traders Daily
AngioDynamics Inc. (ANGO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
387,188 Shares in AngioDynamics, Inc. $ANGO Bought by Western Standard LLC - MarketBeat
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
AngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a 32% Potential Upside with Robust Buy Ratings - DirectorsTalk Interviews
AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis - aboutlawsuits.com
AngioDynamics, Inc. $ANGO Shares Purchased by Lazard Asset Management LLC - MarketBeat
Senior Vice President of Regulatory Affairs Warren Nighan Sold A Bunch Of Shares In AngioDynamics - simplywall.st
Segall Bryant & Hamill LLC Trims Stock Position in AngioDynamics, Inc. $ANGO - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
AngioDynamics (ANGO) SVP Warren Nighan Jr. sells 23,370 shares at $14.72 - Stock Titan
AngioDynamics (NASDAQ: ANGO) insider plans $344K sale of equity awards - Stock Titan
AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Live webcast set for AngioDynamics' Aug. 11 presentation - Stock Titan
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics, Inc. Revenue Breakdown – NASDAQ:ANGO - TradingView
2.19%
8.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):